Victory Capital Management Inc. Acquires 46,199 Shares of Addus HomeCare Co. (NASDAQ:ADUS)

Victory Capital Management Inc. raised its holdings in Addus HomeCare Co. (NASDAQ:ADUS) by 136.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 80,047 shares of the company’s stock after buying an additional 46,199 shares during the period. Victory Capital Management Inc. owned about 0.44% of Addus HomeCare worth $9,294,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of ADUS. UMB Bank n.a. raised its stake in Addus HomeCare by 64.2% in the 2nd quarter. UMB Bank n.a. now owns 225 shares of the company’s stock valued at $26,000 after acquiring an additional 88 shares during the period. Azzad Asset Management Inc. ADV increased its holdings in shares of Addus HomeCare by 1.3% in the second quarter. Azzad Asset Management Inc. ADV now owns 8,436 shares of the company’s stock valued at $980,000 after purchasing an additional 110 shares during the last quarter. Guinness Asset Management LTD raised its position in shares of Addus HomeCare by 3.3% in the second quarter. Guinness Asset Management LTD now owns 5,001 shares of the company’s stock valued at $580,000 after purchasing an additional 158 shares during the period. GAMMA Investing LLC lifted its stake in shares of Addus HomeCare by 40.8% during the 1st quarter. GAMMA Investing LLC now owns 556 shares of the company’s stock worth $57,000 after buying an additional 161 shares during the last quarter. Finally, Louisiana State Employees Retirement System boosted its holdings in shares of Addus HomeCare by 2.5% during the 2nd quarter. Louisiana State Employees Retirement System now owns 8,100 shares of the company’s stock worth $940,000 after buying an additional 200 shares during the period. Institutional investors own 95.35% of the company’s stock.

Addus HomeCare Price Performance

Shares of NASDAQ:ADUS opened at $130.13 on Friday. Addus HomeCare Co. has a 1 year low of $78.35 and a 1 year high of $134.78. The stock has a market capitalization of $2.36 billion, a price-to-earnings ratio of 32.29, a price-to-earnings-growth ratio of 2.33 and a beta of 1.04. The company’s 50 day simple moving average is $125.77 and its 200 day simple moving average is $112.85.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings results on Monday, August 5th. The company reported $1.35 EPS for the quarter, topping analysts’ consensus estimates of $1.21 by $0.14. The company had revenue of $286.90 million during the quarter, compared to analysts’ expectations of $284.90 million. Addus HomeCare had a return on equity of 9.81% and a net margin of 6.18%. Addus HomeCare’s revenue was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.94 EPS. As a group, analysts anticipate that Addus HomeCare Co. will post 4.58 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Roberton James Stevenson sold 217 shares of Addus HomeCare stock in a transaction that occurred on Monday, June 17th. The shares were sold at an average price of $116.13, for a total transaction of $25,200.21. Following the sale, the executive vice president now directly owns 10,217 shares of the company’s stock, valued at approximately $1,186,500.21. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In related news, EVP Roberton James Stevenson sold 217 shares of the business’s stock in a transaction on Monday, June 17th. The stock was sold at an average price of $116.13, for a total transaction of $25,200.21. Following the sale, the executive vice president now owns 10,217 shares in the company, valued at approximately $1,186,500.21. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Esteban Lopez sold 500 shares of the stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $127.50, for a total value of $63,750.00. Following the completion of the transaction, the director now owns 3,366 shares of the company’s stock, valued at $429,165. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 23,134 shares of company stock valued at $3,075,282. 4.60% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the stock. StockNews.com downgraded shares of Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research report on Sunday, July 7th. Oppenheimer boosted their price target on Addus HomeCare from $130.00 to $140.00 and gave the company an “outperform” rating in a research note on Wednesday, August 7th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $141.00 price objective on shares of Addus HomeCare in a report on Tuesday, September 3rd. TD Cowen lifted their target price on Addus HomeCare from $128.00 to $137.00 and gave the stock a “buy” rating in a report on Thursday, August 8th. Finally, Macquarie began coverage on shares of Addus HomeCare in a research note on Friday, June 28th. They issued an “outperform” rating and a $136.00 price target on the stock. One equities research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company. According to MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and an average price target of $127.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.